|
Schlusskurs
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 24.09. | Irlab ernennt Janne Backman zum neuen Verwaltungsratsvorsitzenden | FW |
| 24.09. | IRLAB Therapeutics AB gibt Änderungen im Verwaltungsrat mit Wirkung zum 25. September 2026 bekannt | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.62% | +0.39% | +1.55% | -4.49% | +9.30% | +61.69% | +118.69% | +409.93% | +1’373.13% | 1’056 Mrd. | |
| -1.92% | -0.77% | +0.47% | +3.33% | +29.07% | +47.07% | +71.50% | +62.85% | +127.77% | 655 Mrd. | |
| -1.27% | -0.72% | +2.68% | +3.53% | +15.23% | +17.98% | +76.64% | +141.91% | +319.13% | 471 Mrd. | |
| -1.72% | -4.06% | -0.99% | +3.10% | +6.43% | +36.39% | +39.47% | +3.33% | +44.46% | 342 Mrd. | |
| -0.40% | +3.83% | -1.90% | -4.18% | +10.33% | +22.08% | +28.82% | +56.57% | +56.53% | 277 Mrd. | |
| -0.51% | -1.93% | +3.90% | -13.08% | -9.88% | +12.09% | +11.94% | +40.70% | +147.27% | 257 Mrd. | |
| -0.20% | +1.65% | -2.99% | +15.66% | +27.41% | +52.21% | +55.16% | +94.05% | +152.05% | 226 Mrd. | |
| -1.56% | -1.86% | +2.38% | +18.60% | +22.07% | +33.04% | +99.93% | +111.21% | +92.44% | 189 Mrd. | |
| -0.24% | -2.76% | -13.94% | -20.09% | -22.63% | -28.41% | -60.92% | -17.92% | +79.75% | 170 Mrd. | |
| -1.38% | +1.31% | -0.58% | +16.11% | +13.63% | +18.64% | -14.70% | -35.00% | -15.08% | 164 Mrd. | |
| -0.58% | +1.60% | -3.91% | +4.72% | +15.42% | +32.36% | +50.47% | +187.15% | +515.58% | 134 Mrd. | |
| -0.94% | +1.60% | -5.34% | +8.00% | +17.25% | +43.25% | +8.97% | +4.33% | +17.40% | 130 Mrd. | |
| -0.22% | -2.62% | -0.83% | -6.24% | +1.73% | +22.27% | +24.40% | +5.68% | -9.88% | 98.8 Mrd. | |
| -0.74% | -3.93% | -6.95% | -5.34% | -13.60% | -8.70% | -29.57% | -14.62% | +5.06% | 98.08 Mrd. | |
| -4.18% | -9.64% | -13.32% | -18.00% | -26.05% | -3.02% | +32.03% | +45.39% | +401.73% | 66.5 Mrd. | |
| -1.53% | -3.84% | -1.05% | +12.82% | +18.70% | +29.32% | +22.84% | +52.84% | +18.14% | 60.16 Mrd. | |
| -3.78% | -1.35% | -0.33% | +6.19% | +32.07% | +76.37% | +7.55% | +3.08% | -44.64% | 56.74 Mrd. | |
| +1.30% | -0.35% | +1.70% | +19.33% | +37.64% | +112.86% | +337.56% | +301.02% | +9.69% | 45.31 Mrd. | |
| +2.59% | -0.91% | -3.59% | -6.27% | -23.42% | -34.90% | +1.51% | -9.47% | +181.03% | 43.61 Mrd. | |
| Durchschnitt | -0.98% | +0.30% | -2.26% | +1.77% | +8.46% | +28.56% | +46.44% | +75.95% | +182.71% | 238.95 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -1.08% | +0.91% | -0.52% | +0.66% | +11.54% | +35.95% | +61.27% | +142.28% | +422.90% |
- Börse
- Aktien
- A2PLBE Aktie
- Aktie
- Sektor IRLAB Therapeutics AB
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
